Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Cancer crawled date : 2022 - 03 - 07 save search
Puma Biotechnology to Participate in Breast Cancer Panel at Cowen’s Annual Health Care Conference
Published: 2022-03-07 (Crawled : 19:00) - biospace.com/
PBYI | $5.35 1.52% 1.5% 270K
|
Health Technology
|
| O: -1.59%
H: 0.0%
C: 0.0%
health technology conference cancer biotech iot breast cancer
Curis Announces Gastroenterology Publication of Encouraging Preclinical Data of Emavusertib in Pancreatic Cancers
Published: 2022-03-07 (Crawled : 18:00) - biospace.com/
CRIS | $14.155 -7.36% -7.95% 20K
|
Health Technology
|
| O: 1.35%
H: 1.33%
C: -2.33%
ema preclinical cancer pancreatic pre-clinical
Outlook on the Oral Cancer Treatment Global Market to 2030 - Increase in Number of Pipeline Drugs Presents Opportunities
Published: 2022-03-07 (Crawled : 17:00) - prnewswire.com
SNYNF | $92.9 -2.18% 880
|
Health Technology
|
| O: 7.22%
H: 0.0%
C: 0.0%
VTRS | $11.32 -0.09% -0.09% 4.4M
|
Health Technology
|
| O: -0.7%
H: 1.2%
C: -1.2%
SNY | $46.22 0.63% 0.63% 1.7M
|
Health Technology
|
| O: 1.33%
H: 0.0%
C: 0.0%
treatment drug cancer
NantHealth and Leading Nonprofit Multi-state Health Plan Scale Partnership to Increase Services for Members with Cancer
Published: 2022-03-07 (Crawled : 14:00) - nanthealth.com
NH | $1.35 -46.64% -1.48% 0
|
Technology Services
|
| O: 1.22%
H: 1.06%
C: -2.8%
partnership health state services cancer
Phase 3 TROPiCS-02 Study Met the Primary Endpoint of Progression-Free Survival in Late-Line HR+/HER2- Metastatic Breast Cancer
Published: 2022-03-07 (Crawled : 14:00) - biospace.com/
GILD | $67.76 -1.3% -1.31% 7.7M
|
Health Technology
|
| O: -2.66%
H: 0.0%
C: 0.0%
cs-02 cancer phase 3 breast cancer her2- her2 metastatic breast cancer
Acceptance of SBP-101 Abstract for Poster Presentation at American Association for Cancer Research (AACR)
Published: 2022-03-07 (Crawled : 14:00) - globenewswire.com
PBLA | $0.59 -6.31% 140K
|
Professional, Scientific, and T...
|
| O: -2.14%
H: 2.73%
C: 0.0%
sbp-101 america pos research presentation cancer
LAVA Therapeutics Presents Initial LAVA-051 Clinical Data at the ESMO Targeted Anticancer Therapies Congress 2022
Published: 2022-03-07 (Crawled : 14:00) - globenewswire.com
LVTX | $2.97 -5.11% -5.39% 130K
|
|
| O: 5.3%
H: 1.31%
C: -3.28%
lava-051 therapeutics cancer therapy
Helio Health Announces Publication of ENCORE Data in Hepatology Communications, Demonstrating Superior Performance of HelioLiver for Early Detection of Liver Cancer
Published: 2022-03-07 (Crawled : 13:30) - biospace.com/
FLGT | $20.74 -1.57% -1.59% 190K
|
Health Services
|
| O: -2.08%
H: 0.0%
C: 0.0%
health liver communication cancer communications perform
Harpoon Therapeutics Granted Orphan Drug Designation for HPN328 for Treatment of Small Cell Lung Cancer
Published: 2022-03-07 (Crawled : 13:00) - globenewswire.com
HARP | $23.01 0.07% 6.6M
|
Health Technology
|
| O: -7.99%
H: 11.37%
C: 11.0%
hpn328 treatment drug granted therapeutics drug designation cel orphan drug lung cancer cancer grant designation
Repare Therapeutics Presents RP-3500 Dose Selection Phase 1 Monotherapy Safety Data from the Phase 1/2 TRESR Clinical Trial at the 2022 ESMO Targeted Anticancer Therapies Congress
Published: 2022-03-07 (Crawled : 12:30) - biospace.com/
RPTX 4 | $3.445 -5.62% -5.95% 90K
|
Health Technology
|
| O: -5.48%
H: 5.02%
C: 1.56%
rp-3500 500 trial therapeutics phase 1 therapy cancer phase 2 phase 3
Targovax ASA and Agenus announce collaboration on mutant KRAS cancer vaccine adjuvanted with QS-21 STIMULON™
Published: 2022-03-07 (Crawled : 12:30) - globenewswire.com
AGEN 4 | $6.495 -20.31% -25.48% 1.5M
|
Health Technology
|
| O: -1.19%
H: 0.0%
C: 0.0%
qs-21 collaboration cancer vaccine
HUTCHMED Receives a US$15 million Milestone from AstraZeneca for Initiating Start-up Activities for a Global Phase III Study of ORPATHYS® in Lung Cancer
Published: 2022-03-07 (Crawled : 05:00) - globenewswire.com
AZNCF | $138.88 -4.19% 960
|
Health Technology
|
| O: 2.76%
H: 0.0%
C: -1.8%
HCM | $17.64 -1.34% -1.36% 63K
|
Health Technology
|
| O: -10.68%
H: 0.0%
C: 0.0%
AZN | $68.75 -0.26% -0.26% 7.6M
|
Health Technology
|
| O: -1.33%
H: 0.0%
C: 0.0%
orpathys star lung cancer one cancer milestone
Gainers vs Losers
| 49% | 51% |
Top 10 Gainers
KAVL | $6.275 135.02% 57.45% 44M
|
Wholesale Trade
PXMD | $0.7375 79.09% 44.16% 4.5M
|
Health Technology
DYNT | $0.371 -5.12% 43.09% 3.3M
|
Health Technology
LGVN P 3 d | $2.94 73.96% 42.52% 57M
|
HUBC | $1.94 49.23% 32.99% 73M
|
n/a
SPCB | $0.4044 46.52% 31.75% 130M
|
Electronic Technology
ONVO | $1.34 32.66% 24.62% 54M
|
Health Technology
OMQS | $0.6869 32.1% 24.3% 3.6M
|
Professional, Scientific, and T...
SNPO | $10.555 29.67% 22.88% 4M
|
AMBI | $3.72 -26.77% 21.77% 9.8K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.